LifeAssays AB (publ) logo

LIFE B - LifeAssays AB (publ) Share Price

SEK0.974 -0.0  -4.5%

Last Trade - 10:37am

Sector
Healthcare
Size
Micro Cap
Market Cap £5.72m
Enterprise Value £6.92m
Revenue £553k
Position in Universe 1616th / 1783
Bullish
Bearish
Unlock LIFE B Revenue
Momentum
Relative Strength (%)
1m -22.0%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -32.0%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
3.96 4.79 7.57 7.10 5.48 5.40 +6.4%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 June 2020, LifeAssays AB (publ) revenues increased 40% to SEK3.6M. Net loss decreased 58% to SEK4.5M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Personnel cost decrease of 32% to SEK4.3M (expense), Other external expenses decrease of 47% to SEK1.8M (expense), Interest expense decrease of 61% to SEK641K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

LIFE B Revenue Unlock LIFE B Revenue

Net Income

LIFE B Net Income Unlock LIFE B Revenue

Normalised EPS

LIFE B Normalised EPS Unlock LIFE B Revenue

PE Ratio Range

LIFE B PE Ratio Range Unlock LIFE B Revenue

Dividend Yield Range

LIFE B Dividend Yield Range Unlock LIFE B Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
LIFE B EPS Forecasts Unlock LIFE B Revenue
Profile Summary

LifeAssays publ AB is a Sweden-based diagnostic company. It is engaged in the provision of in-house diagnostic testing for community health centers and physicians, as well as for home use and veterinary applications. The Company develops and markets point-of-care testing (POCT) instruments and technology for the diagnosis of diabetes, renal dysfunction and cardiovascular diseases. The Company’s business portfolio comprises such products, as LifeAssays Canine CRP Test Kit, which monitors inflammation in dogs for early disease intervention; LifeAssays CRP Test Kit, which is a reagent kit for high-sensitive C-Reactive Protein (hsCRP) and normal range C-Reactive Protein (CRP) in whole blood; LifeAssays Reader, which utilizes a disposable algorithm chip containing all reagent identification data, as well as, a self-executable algorithm; and LifeAssays Vet Reader, which offers veterinary practitioners all the functions provided with the LifeAssays Reader.

Directors
Last Annual December 31st, 2019
Last Interim June 30th, 2020
Public Since June 28, 2002
No. of Shareholders: n/a
No. of Employees: 12
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange Nordic Growth Market - Stockholm
Shares in Issue 65,167,473
Free Float (0.0%)
Eligible for
ISAs
SIPPs
LIFE B Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for LIFE B
Upcoming Events for LIFE B
Frequently Asked Questions for LifeAssays AB (publ)
What is the LifeAssays AB (publ) share price?

As of 10:37am, shares in LifeAssays AB (publ) are trading at SEK0.974, giving the company a market capitalisation of £5.72m. This share price information is delayed by 15 minutes.

How has the LifeAssays AB (publ) share price performed this year?

Shares in LifeAssays AB (publ) are currently trading at SEK0.974 and the price has moved by 0.119k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the LifeAssays AB (publ) price has moved by 0.145k% over the past year.

What are the analyst and broker recommendations for LifeAssays AB (publ)?

There are no analysts currently covering LifeAssays AB (publ).

When will LifeAssays AB (publ) next release its financial results?

LifeAssays AB (publ) is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the LifeAssays AB (publ) dividend yield?

LifeAssays AB (publ) does not currently pay a dividend.

Does LifeAssays AB (publ) pay a dividend?

LifeAssays AB (publ) does not currently pay a dividend.

When does LifeAssays AB (publ) next pay dividends?

LifeAssays AB (publ) does not currently pay a dividend.

How do I buy LifeAssays AB (publ) shares?

To buy shares in LifeAssays AB (publ) you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of LifeAssays AB (publ)?

Shares in LifeAssays AB (publ) are currently trading at SEK0.974, giving the company a market capitalisation of £5.72m.

Where are LifeAssays AB (publ) shares listed? Where are LifeAssays AB (publ) shares listed?

Here are the trading details for LifeAssays AB (publ):

Country of listing: Sweden
Exchange: NGM
Ticker Symbol: LIFE B
What kind of share is LifeAssays AB (publ)?

Based on an overall assessment of its quality, value and momentum, LifeAssays AB (publ) is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a LifeAssays AB (publ) share price forecast 2020?

We were not able to load any forecast data for LifeAssays AB (publ).

How can I tell whether the LifeAssays AB (publ) share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like LifeAssays AB (publ). Over the past six months, the relative strength of its shares against the market has been 57.26%. At the current price of SEK0.974, shares in LifeAssays AB (publ) are trading at 7.1% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the LifeAssays AB (publ) PE Ratio?

We were not able to find PE ratio data for LifeAssays AB (publ).

Who are the key directors of LifeAssays AB (publ)?

LifeAssays AB (publ)'s management team is headed by:

Anders Norling - CHM
Anders Ingvarsson - CEO
Bo Uneus - DRC
Margareta Kriz - CFO
Bjorn Ekberg - OTH
Min Lu - OTH
Filiz Ibraimi - OTH
Tom Liber - DSL
Peter Forssberg - DRC
Khaled Terike - OTH
Felix Sandgren - OTH
Anders Drews - OTH
Pekka Ronka - DRC
Who are the major shareholders of LifeAssays AB (publ)?

Here are the top five shareholders of LifeAssays AB (publ) based on the size of their shareholding:

Fällström (Johan) Individual Investor
Percentage owned: 10.69% (8.05m shares)
Häglund (Fredrik) Individual Investor
Percentage owned: 5.29% (3.98m shares)
Avanza Bank Holding AB Corporation
Percentage owned: 4.88% (3.67m shares)
Staffansgården .Trää AB Corporation
Percentage owned: 3.45% (2.60m shares)
Nordnet AB Corporation
Percentage owned: 3.22% (2.42m shares)
Similar to LIFE B
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.